Skip to main content

LU C22 (Fenofibrate (Micronized) 130 mg)

Pill with imprint LU C22 is Green & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 130 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 130 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU C22

Fenofibrate (Micronized)

Imprint
LU C22
Strength
130 mg
Color
Green & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
55111-0395
Inactive Ingredients
gelatin, hypromelloses, ferric oxide yellow, ferrosoferric oxide, potassium hydroxide, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, D&C Yellow No. 10, FD&C Blue No. 2, raw sugar, ammonio methacrylate copolymer type A

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.